JP2012519671A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012519671A5 JP2012519671A5 JP2011552477A JP2011552477A JP2012519671A5 JP 2012519671 A5 JP2012519671 A5 JP 2012519671A5 JP 2011552477 A JP2011552477 A JP 2011552477A JP 2011552477 A JP2011552477 A JP 2011552477A JP 2012519671 A5 JP2012519671 A5 JP 2012519671A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- early stage
- dicitide
- tgf
- prophylactic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- 206010029098 Neoplasm skin Diseases 0.000 claims 3
- 208000000453 Skin Neoplasms Diseases 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 230000002401 inhibitory effect Effects 0.000 claims 3
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 claims 2
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 claims 2
- 230000000069 prophylactic effect Effects 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000009621 actinic keratosis Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 201000010153 skin papilloma Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ESP200900694 | 2009-03-06 | ||
| ES200900694A ES2347627B1 (es) | 2009-03-06 | 2009-03-06 | Peptido para el tratamiento profilactico o terapeutico de tumores de la piel en estadios iniciales. |
| PCT/ES2010/070121 WO2010100310A1 (es) | 2009-03-06 | 2010-03-04 | Péptido para el tratamiento profiláctico o terapéutico de tumores de la piel en estadios iniciales |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012519671A JP2012519671A (ja) | 2012-08-30 |
| JP2012519671A5 true JP2012519671A5 (enExample) | 2013-04-18 |
Family
ID=42709234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011552477A Pending JP2012519671A (ja) | 2009-03-06 | 2010-03-04 | 初期段階の皮膚腫瘍の予防的又は治療的処置のためのペプチド |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8658599B2 (enExample) |
| EP (1) | EP2404611A4 (enExample) |
| JP (1) | JP2012519671A (enExample) |
| CN (1) | CN102341115A (enExample) |
| AR (1) | AR075783A1 (enExample) |
| AU (1) | AU2010219857A1 (enExample) |
| BR (1) | BRPI1013363A8 (enExample) |
| CA (1) | CA2753461A1 (enExample) |
| ES (1) | ES2347627B1 (enExample) |
| MX (1) | MX2011009225A (enExample) |
| RU (1) | RU2011140477A (enExample) |
| TW (1) | TW201036625A (enExample) |
| WO (1) | WO2010100310A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014183018A2 (en) * | 2013-05-10 | 2014-11-13 | Southern Research Institute | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES THROUGH INHIBITING TGF-β ACTIVITY |
| CN110483648A (zh) * | 2019-08-27 | 2019-11-22 | 南京安吉生物科技有限公司 | 一种融合多肽及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2146552B1 (es) | 1998-11-24 | 2001-04-16 | Inst Cientifico Tecnol Navarra | Peptidos inhibidores de tgf/31 |
| EP1722823A2 (en) * | 2004-02-27 | 2006-11-22 | Antisense Pharma GmbH | Pharmaceutical composition |
| JP5112322B2 (ja) | 2005-10-24 | 2013-01-09 | プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダ | 免疫応答調節剤の製造におけるＴＧＦ−β１インヒビターペプチドの使用 |
| BRPI0915093A2 (pt) * | 2008-06-13 | 2015-10-27 | Proyecto Biomedicina Cima Sl | conjugados para a administração de compostos biologicamente ativos |
-
2009
- 2009-03-06 ES ES200900694A patent/ES2347627B1/es not_active Expired - Fee Related
-
2010
- 2010-03-03 AR ARP100100633A patent/AR075783A1/es not_active Application Discontinuation
- 2010-03-04 BR BRPI1013363A patent/BRPI1013363A8/pt not_active IP Right Cessation
- 2010-03-04 AU AU2010219857A patent/AU2010219857A1/en not_active Abandoned
- 2010-03-04 CA CA2753461A patent/CA2753461A1/en not_active Abandoned
- 2010-03-04 US US13/255,059 patent/US8658599B2/en not_active Expired - Fee Related
- 2010-03-04 JP JP2011552477A patent/JP2012519671A/ja active Pending
- 2010-03-04 WO PCT/ES2010/070121 patent/WO2010100310A1/es not_active Ceased
- 2010-03-04 RU RU2011140477/10A patent/RU2011140477A/ru not_active Application Discontinuation
- 2010-03-04 CN CN2010800105516A patent/CN102341115A/zh active Pending
- 2010-03-04 EP EP10748370A patent/EP2404611A4/en not_active Withdrawn
- 2010-03-04 MX MX2011009225A patent/MX2011009225A/es not_active Application Discontinuation
- 2010-03-05 TW TW099106502A patent/TW201036625A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL255752B (en) | Compounds, pharmaceutical compositions comprising the same and uses thereof for treating cardiovasclar disease, an inflammatory disease or cancer | |
| SG158870A1 (en) | Bendamustine pharmaceutical compositions for lyophilisation | |
| CY1119865T1 (el) | Φαρμακευτικες συνθεσεις για την αντιμετωπιση της νοσου του παρκινσον | |
| IN2015DN00376A (enExample) | ||
| WO2009039397A3 (en) | Substituted amides, methods of making, use thereof for the treatment of diseases such as cancer | |
| AR090885A1 (es) | Uso de laquinimod en alta dosis para el tratamiento de la esclerosis multiple | |
| WO2018005519A3 (en) | Cancer treatment combinations | |
| JP2014521735A5 (enExample) | ||
| HK1214765A1 (zh) | 包含b-raf抑制剂和组蛋白脱乙酰基酶抑制剂的药物组合以及其在治疗增生性疾病中的用途 | |
| WO2008131056A3 (en) | Sustained release monoeximic formulations of opioid and nonopioid analgesics | |
| HK1200716A1 (zh) | 使用胞苷類似物的口服製劑治療癌症的方法 | |
| MX2009006327A (es) | Compuestos heterociclicos y metodos de uso de los mismos. | |
| JP2015537009A5 (enExample) | ||
| JP2015527374A5 (enExample) | ||
| MX2024007642A (es) | Uso de tabletas de desintegracion oral de riluzol para tratar enfermedades. | |
| WO2017182873A3 (en) | Peptide-oligourea foldamer compounds and methods of their use | |
| JP2015508765A5 (enExample) | ||
| JP2015507020A5 (enExample) | ||
| BR112023025552A2 (pt) | Composições estabilizadas de apilimod e usos das mesmas | |
| UA115250C2 (uk) | Фармацевтичні комбінації | |
| EA201270747A1 (ru) | Композиции и способы для профилактики и лечения ран | |
| UA94036C2 (ru) | Фармацевтическая композиция бендамустина, предназначенная для лиофилизации | |
| JP2012519671A5 (enExample) | ||
| WO2016122288A3 (ko) | 베르베논 유도체 및 재관류 치료제를 포함하는 뇌혈관 질환, 동맥경화증 또는 심혈관 질환 치료 또는 예방용 병용 제제 | |
| JP2008533079A5 (enExample) |